Tibet Weixinkang Medicine Co., Ltd. (603676.SS)

CNY 10.79

(0.47%)

Market Cap (In CNY)

4.69 Billion

Revenue (In CNY)

1.32 Billion

Net Income (In CNY)

214.01 Million

Avg. Volume

2.91 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
6.3-11.36
PE
-
EPS
-
Beta Value
0.057
ISIN
CNE100002QQ3
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Yong Zhang
Employee Count
-
Website
https://www.wxkpharma.com
Ipo Date
2017-07-21
Details
Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company's products include parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, antibiotics, and medicine for digestive system and liver diseases. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd. in 2015. Tibet Weixinkang Medicine Co., Ltd. was founded in 2006 and is based in Lhasa, China.